Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
Machaon M Bonafede,1 Barbara H Johnson,1 Crystal Watson2 1Truven Health Analytics, Cambridge, MA, USA; 2Biogen Idec, Weston, MA, USA Objectives: To evaluate multiple sclerosis (MS)-related health care-resource utilization and costs prior to and after initiating natalizumab in the US. Materials and m...
Saved in:
Main Authors: | Bonafede MM (Author), Johnson BH (Author), Watson C (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Health care resource utilization before and after natalizumab initiation among patients with multiple sclerosis in Germany
by: Watson C, et al.
Published: (2017) -
Natalizumab in the treatment of multiple sclerosis
by: Brandon A Brown
Published: (2009) -
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
by: Johnson BH, et al.
Published: (2016) -
Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
by: Francesco Patti, et al.
Published: (2009) -
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
by: Mehdi Rezaee, et al.
Published: (2022)